Innate Pharma S.A. (EPA:IPH)

France · Delayed Price · Currency is EUR

1.660

+0.432 (35.18%)

May 14, 2026, 5:38 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology				57.67M	24.70M	69.77M	85.45M	93.95M
Biotechnology Growth				133.47%	-64.60%	-18.35%	-9.05%	113.37%
Total				57.67M	24.70M	69.77M	85.45M	93.95M
Total Growth				133.47%	-64.60%	-18.35%	-9.05%	113.37%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
France				57.67M	24.70M	69.77M	85.45M	93.95M
France Growth				133.47%	-64.60%	-18.35%	-9.05%	113.37%
Total				57.67M	24.70M	69.77M	85.45M	93.95M
Total Growth				133.47%	-64.60%	-18.35%	-9.05%	113.37%

Source: S&P Global Market Intelligence.